首页> 外文期刊>International Journal of Applied and Basic Medical Research >Evaluating the effectiveness of gel formulation of irradiated seed lectin Cratylia mollis during bone repair in rats
【24h】

Evaluating the effectiveness of gel formulation of irradiated seed lectin Cratylia mollis during bone repair in rats

机译:评估辐照的种子凝集素Cartylia mollis凝胶制剂在大鼠骨修复过程中的有效性

获取原文
           

摘要

Context:Regeneration corresponds to the replacement of damaged cells with ones that have the same morphology and function. For experimental evaluation of materials that may favor the process of bone healing, defects are created with dimensions that prevent spontaneous regeneration. For the development and use of new drugs, it is necessary to study its effects in vitro, which depends on the formulation, concentration, and rate of irradiation in vivo and the route and frequency of administration; thus, it is possible to characterize the physiological and molecular mechanisms involved in the response and cellular effects.Objective:The objective of this study was to assess the effect of Cramoll-1,4 on the process of bone repair.Materials and Methods:A formulation of biopharmaceutical lectin Cramoll-1,4 at a concentration of 300 mg/100 mL was applied in a single application via gamma radiation and its effect on the process of bone repair in rats was assessed.Results:Histologically, it was observed that the bone defect is coated by loose connective tissue rich in fibroblasts, providing a range similar to the thick bone original and competing with site of new bone formation. This prevented direct contact between the formulation and experimental bone tissue, as, despite its proven effectiveness in experiments on the repair of skin lesions, the formulation used did not promote bone stimulation that would have promoted the tissue repair process.Conclusion:Because of the direct interference of loose tissue repair that prevented direct contact of the implant with the bone interface, the formulation did not promote bone stimulation.
机译:背景:再生是指用具有相同形态和功能的细胞替换受损细胞。为了对可能有利于骨愈合过程的材料进行实验评估,会产生尺寸可防止自发再生的缺陷。为了开发和使用新药,有必要在体外研究其作用,这取决于制剂,体内辐射的浓度和速率以及体内的给药途径和频率。目的:本研究的目的是评估Cramoll-1,4对骨骼修复过程的影响。材料与方法:A通过γ射线单次施用生物制药凝集素Cramoll-1,4的配方,剂量为300 mg / 100 mL,并评估了其对大鼠骨修复过程的影响。结果:从组织学上观察,骨缺损由富含成纤维细胞的疏松结缔组织覆盖,提供的范围类似于原始的厚骨,并与新骨形成部位竞争。这阻止了制剂与实验性骨组织之间的直接接触,因为尽管它在修复皮肤损伤的实验中被证明是有效的,但所使用的制剂并不能促进原本可以促进组织修复过程的骨刺激。松散的组织修复的干扰阻止了植入物与骨界面的直接接触,因此该制剂没有促进骨刺激。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号